TheEdgeResearch
Home / Stocks / GRUSF

Grown Rogue International Inc. (GRUSF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.46 ▼ -0.37%
Market Cap
$114.6M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-1.04
52-Wk Range
0.27-0.52
CEO
J. Obie Strickler
Country
US
Currency
USD

Grown Rogue International Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Medford, OR, US. The stock last traded at $0.46, down 0.37% on the session, giving a market capitalisation of $114.6M. On trailing twelve-month figures it carries a trailing P/E of -30.19, a net margin of -6.4%. Its beta of -1.04 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-30.19
Price / Sales
2.78
Price / Book
7.51
EV / EBITDA
80.95
Gross margin
45.0%
Operating margin
-3.3%
Net margin
-6.4%
Return on equity
Debt / equity
1.79
Current ratio
2.59
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
204
IPO date
2010-10-15
Headquarters
Medford, OR, US
About Grown Rogue International Inc.

Grown Rogue International Inc., operating through its subsidiary entities, focuses on the cultivation and retail of cannabis products across the United States. Its diverse product portfolio includes a variety of cannabis flower, such as indica, sativa, and hybrid strains, alongside edibles, vaporization cartridges, pre-rolled joints, and concentrated cannabis forms. The company's merchandise is distributed and sold primarily through licensed dispensaries. Grown Rogue International Inc.'s corporate headquarters are located in Medford, Oregon.

Comparable companies

Grown Rogue International Inc. is most often compared with the following Healthcare names:

BIOYFETSTGGBXFHSCHFIUGNFLOVFFMSCLFORXOFPLNHSHIEF
More research on GRUSF
GRUSF technical analysis GRUSF TheEdge Score Compare against peers
Open full interactive analysis & DCF →